Michael Ganz, an assistant Professor of Society, Human Development, and Health at Harvard School of Public Health, has examined the cost of autism for US society //and has found that the disease costs a person $3.2 million over the entire life span. Ganz has published his research in the new book Understanding Autism: From Basic Neuroscience to Treatment (CRC Press, 2006). In his study, titled, “The Costs of Autism,” Ganz says that autism costs $35 billion per year for the US economy.
Ganz’s analysis of the costs includes direct and indirect medical costs associated with the disorder. But he believes the $35 billion annual societal cost for caring for and treating people with autism likely underestimates the true costs because there are a number of other services that are used to support individuals with autism, such as alternative therapies and other family out-of-pocket expenses, that are difficult to measure. In addition, Ganz believes that the level of cost could be higher if there were more useful and widespread treatment options available. “Given that the federal autism research budget has been historically less than $100 million per year and given that research budgets for other conditions with similar numbers of affected individuals are sometimes orders of magnitude higher, I hope that my research can help focus more attention on directing more resources toward finding prevention and treatment options for autism,” Ganz said. (For comparison purposes, he notes estimated annual costs of other conditions, including Alzheimer’s disease ($91 billion); mental retardation ($51 billion); anxiety ($47 billion); and schizophrenia ($33 billion).
Autism is a pervasive developmental disorder (PDD) that involves severe deficits in a person’s ability to communicate and interact with others. Children with autism often have trouble using their imagination, have a limited range of interests, and may show repetitive patterns of behavior or body movements
. The disorder is often associated with some degree of mental retardation. Autism is the most prevalent PDD and the most common of all serious childhood disorders. It affects an estimated 1.5 million Americans and is increasing at a rate of 10-17 percent each year. It is four times more common in boys than in girls. The exact cause of autism is not known and there is currently no cure for the disorder.
Ganz broke down the total costs of autism into two components: direct and indirect costs. Direct costs include direct medical costs, such as physician and outpatient services, prescription medication, and behavioral therapies (estimated to cost, on average, more than $29,000 per person per year) and direct non-medical costs, such as special education, camps, and child care (estimated to annually cost more than $38,000 for those with lower levels of disability and more than $43,000 for those with higher levels).
Indirect costs equal the value of lost productivity resulting from a person having autism, for example, the difference in potential income between someone with autism and someone without. It also captures the value of lost productivity for an autistic person’s parents. Examples include loss of income due to reduced work hours or not working altogether. Ganz estimates that annual indirect costs for autistic individuals and their parents range from more than $39,000 to nearly $130,000.
Since people with autism receive services from a wide variety of sources, Ganz believes future research efforts should focus on identifying those sources and linking those costs to non-financial data about the burdens of autism. These complementary sources of data can provide a richer picture that will be useful to policymakers in the future to assist them in devoting resources to address the financial and non-financial effects of autism.
Related medicine news :1
. Drug Prices in India to be Monitored - NPPA to Tie up with ORG 2
. Price Of Alcohol Does Not Influence Consumption3
. Delhi Sees Sharp Decline In Chicken Prices4
. Prices of eggs, egging its way upwards5
. Chicken Prices Show an Upward Trend – Consumers, Not Scared Chicken Anymor6
. The Price Paid for New Lifestyle7
. Drug Prices Hit The Roof In Malaysia8
. Expanding Price Control Detrimental for Pharma Companies: CII9
. IVF Price To Be Reduced If Women Opt For Egg Sharing Scheme10
. Fuel Price Hike Triggers Violent Protests In Nepal11
. Drug Prices Rising Faster Than Inflation